|
US2969364A
(en)
|
1957-12-26 |
1961-01-24 |
Upjohn Co |
Derivatives of 5-amino uracil
|
|
US3008491A
(en)
|
1959-05-04 |
1961-11-14 |
Chapman Valve Mfg Co |
Valve for concentric pipe lines
|
|
US3012976A
(en)
|
1959-11-02 |
1961-12-12 |
Miles Lab |
Specific test composition for occult blood
|
|
US3008281A
(en)
|
1960-07-14 |
1961-11-14 |
Nat Dairy Prod Corp |
Conveyor
|
|
US3299104A
(en)
|
1963-04-09 |
1967-01-17 |
Leo Ab |
Certain steroid nu-bis-(haloethyl)-carbamates
|
|
JPS59186924A
(ja)
|
1983-04-08 |
1984-10-23 |
Kureha Chem Ind Co Ltd |
ヒト免疫グロブリン結合抗腫瘍剤
|
|
US5093330A
(en)
|
1987-06-15 |
1992-03-03 |
Ciba-Geigy Corporation |
Staurosporine derivatives substituted at methylamino nitrogen
|
|
US5035878A
(en)
|
1988-09-12 |
1991-07-30 |
University Of Rochester |
Use of dithiocarbamates to counteract myelosuppression
|
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
|
US5395855A
(en)
|
1990-05-07 |
1995-03-07 |
Ciba-Geigy Corporation |
Hydrazones
|
|
US5484612A
(en)
|
1993-09-22 |
1996-01-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
|
|
US6326469B1
(en)
|
1994-04-22 |
2001-12-04 |
Sugen, Inc. |
Megakaryocytic protein tyrosine kinases
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
MX9800215A
(es)
|
1995-07-06 |
1998-03-31 |
Novartis Ag |
Pirrolopirimidas y procesos para su preparacion.
|
|
US6011069A
(en)
|
1995-12-26 |
2000-01-04 |
Nisshin Flour Milling Co., Ltd. |
Multidrug resistance inhibitors
|
|
US20020077461A1
(en)
|
1996-04-24 |
2002-06-20 |
Soren Bjorn |
Pharmaceutical formulation
|
|
DK0923941T3
(da)
|
1996-06-27 |
2006-09-18 |
Chugai Pharmaceutical Co Ltd |
Midler mod myelom der skal anvendes sammen med nitrogensennepantitumormidler
|
|
US6121245A
(en)
|
1997-01-29 |
2000-09-19 |
Firshein; Richard N. |
Method of treating cancer using alkylglycerols in conjunction with chemotherapy
|
|
CO4950519A1
(es)
|
1997-02-13 |
2000-09-01 |
Novartis Ag |
Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
|
|
US20040072889A1
(en)
|
1997-04-21 |
2004-04-15 |
Pharmacia Corporation |
Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
|
|
CA2294247C
(en)
|
1997-07-01 |
2004-10-26 |
Atherogenics, Inc. |
Antioxidant enhancement of therapy for hyperproliferative conditions
|
|
GB9721069D0
(en)
|
1997-10-03 |
1997-12-03 |
Pharmacia & Upjohn Spa |
Polymeric derivatives of camptothecin
|
|
EP1080103A4
(en)
|
1998-05-21 |
2003-07-02 |
Isis Pharmaceuticals Inc |
PREPARATIONS AND METHOD FOR THE NON-PARENTERAL ADMINISTRATION OF OLIGONUCLEOTIDES
|
|
WO1999063929A2
(en)
|
1998-06-08 |
1999-12-16 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
|
KR20000011247A
(ko)
*
|
1998-07-23 |
2000-02-25 |
김윤 |
다당류를이용한대장선택성약물전달조성물및약학제제
|
|
ATE459616T1
(de)
|
1998-08-11 |
2010-03-15 |
Novartis Ag |
Isochinoline derivate mit angiogenesis-hemmender wirkung
|
|
US6326390B1
(en)
|
1998-08-25 |
2001-12-04 |
King Pharmaceuticals Reseach And Development, Inc. |
Use of adenosine A3 receptor antagonists to inhibit tumor growth
|
|
WO2000059509A1
(en)
|
1999-03-30 |
2000-10-12 |
Novartis Ag |
Phthalazine derivatives for treating inflammatory diseases
|
|
US7534866B2
(en)
|
2005-10-19 |
2009-05-19 |
Ibc Pharmaceuticals, Inc. |
Methods and compositions for generating bioactive assemblies of increased complexity and uses
|
|
WO2008109417A1
(en)
|
2007-03-02 |
2008-09-12 |
Case Western Reserve University |
Mgmt inhibitor combinations for the treatment of neoplastic disorders
|
|
US6635677B2
(en)
|
1999-08-13 |
2003-10-21 |
Case Western Reserve University |
Methoxyamine combinations in the treatment of cancer
|
|
US7811981B2
(en)
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
|
US20030072794A1
(en)
|
2000-06-09 |
2003-04-17 |
Teni Boulikas |
Encapsulation of plasmid DNA (lipogenes™) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes
|
|
ES2344831T3
(es)
|
2000-06-23 |
2010-09-08 |
Mitsubishi Tanabe Pharma Corporation |
Potenciadores de un efecto antitumoral.
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
MXPA03003895A
(es)
|
2000-10-30 |
2003-07-28 |
Euro Celtique Sa |
Formulaciones de hidrocodona de liberacion controlada.
|
|
ITMI20002358A1
(it)
|
2000-10-31 |
2002-05-01 |
Flavio Moroni |
Derivati di tieno ,2, 3-c|isochinolin-3-one come inibitori della poli(a dp-ribosio)polimerasi
|
|
US7619005B2
(en)
|
2000-11-01 |
2009-11-17 |
Cognition Pharmaceuticals Llc |
Methods for treating cognitive impairment in humans with Multiple Sclerosis
|
|
US20100098691A1
(en)
|
2001-01-24 |
2010-04-22 |
S'bio Pte Ltd |
Combination of benzimidazole anti-cancer agent and a second anti-cancer agent
|
|
AR035885A1
(es)
|
2001-05-14 |
2004-07-21 |
Novartis Ag |
Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
|
|
AU2002320122B2
(en)
|
2001-06-21 |
2007-07-26 |
Genentech, Inc. |
Sustained release formulation
|
|
US20030158118A1
(en)
|
2001-11-26 |
2003-08-21 |
Weidner Morten Sloth |
Combination of cimetidine and cysteine derivatives for treating cancer
|
|
US7045534B2
(en)
|
2002-02-12 |
2006-05-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods of reducing angiogenesis
|
|
WO2003070823A2
(en)
|
2002-02-20 |
2003-08-28 |
The General Hospital Corporation |
Conjugates comprising a biodegradable polymer and uses therefor
|
|
US8580782B2
(en)
|
2002-09-04 |
2013-11-12 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
|
|
CA2504665C
(en)
|
2002-11-12 |
2012-12-18 |
Jewish General Hospital |
Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia
|
|
DE60330187D1
(de)
|
2002-12-30 |
2009-12-31 |
Celgene Corp |
Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen
|
|
CA2517256C
(en)
|
2003-02-26 |
2013-04-30 |
Sugen, Inc. |
Aminoheteroaryl compounds as protein kinase inhibitors
|
|
KR20050120663A
(ko)
|
2003-03-24 |
2005-12-22 |
세쿠오이아 파마큐티컬스 인코오퍼레이티드 |
장기간 작용하는 생물학적 활동 컨쥬게이트들
|
|
WO2004094409A1
(en)
|
2003-03-27 |
2004-11-04 |
Lankenau Institute For Medical Research |
Novel ido inhibitors and methods of use
|
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
|
WO2004103958A2
(en)
|
2003-05-19 |
2004-12-02 |
Michigan State University |
Preparation of hymenialdisine derivatives and use thereof
|
|
US7842835B2
(en)
|
2003-07-07 |
2010-11-30 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
|
ES2317047T3
(es)
|
2003-08-07 |
2009-04-16 |
Schering Corporation |
Nuevos inhibidores de la farnesil proteina transferasa como agentes antitumorales.
|
|
WO2005023246A1
(en)
|
2003-09-04 |
2005-03-17 |
Aventis Pharmaceuticals Inc. |
Substituted indoles as inhibitors of poly (adp-ribose) polymerase (parp)
|
|
HUP0303313A2
(hu)
|
2003-10-09 |
2005-07-28 |
Richter Gedeon Vegyészeti Gyár Rt. |
Transzdermális gyógyszerkészítmények
|
|
US7491725B2
(en)
|
2004-02-06 |
2009-02-17 |
Bristol-Myers Squibb Company |
Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
|
|
US8435539B2
(en)
|
2004-02-13 |
2013-05-07 |
Immunomedics, Inc. |
Delivery system for cytotoxic drugs by bispecific antibody pretargeting
|
|
US8652484B2
(en)
|
2004-02-13 |
2014-02-18 |
Immunomedics, Inc. |
Delivery system for cytotoxic drugs by bispecific antibody pretargeting
|
|
US7910621B2
(en)
|
2004-03-22 |
2011-03-22 |
The Regents Of The University Of Michigan |
Small molecule antagonists of XIAP family proteins
|
|
US7754897B2
(en)
|
2005-06-15 |
2010-07-13 |
Cardiome Pharma Corp. |
Synthetic processes for the preparation of aminocyclohexyl ether compounds
|
|
WO2005097747A1
(en)
|
2004-04-05 |
2005-10-20 |
Aton Pharma, Inc. |
Histone deacetylase inhibitor prodrugs
|
|
TW200538149A
(en)
|
2004-05-20 |
2005-12-01 |
Telik Inc |
Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound
|
|
TW200600091A
(en)
|
2004-05-21 |
2006-01-01 |
Telik Inc |
Sulfonylethyl phosphorodiamidates
|
|
MXPA06014933A
(es)
|
2004-06-30 |
2007-02-28 |
Janssen Pharmaceutica Nv |
Derivados de 2-alquil quinazolinona sustituidos como inhibidores de poli(adp-ribosa) polimerasa-1.
|
|
WO2006014729A2
(en)
|
2004-07-20 |
2006-02-09 |
Genentech, Inc. |
Inhibitors of angiopoietin-like 4 protein, combinations, and their use
|
|
SE0402025D0
(sv)
|
2004-08-13 |
2004-08-13 |
Active Biotech Ab |
Treatment of hyperproliferative disease with superantigens in combination with another anticancer agent
|
|
US20060100226A1
(en)
|
2004-09-10 |
2006-05-11 |
Sikorski James A |
2-Thiopyrimidinones as therapeutic agents
|
|
WO2006078711A2
(en)
|
2005-01-19 |
2006-07-27 |
Mgi Gp, Inc. |
Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting parp
|
|
NZ560712A
(en)
|
2005-02-17 |
2010-12-24 |
Synta Pharmaceuticals Corp |
(3,4,5-trisubstituted-phenyl)isoxazole combretastin derivatives for the treatment of disorders
|
|
US7872050B2
(en)
|
2005-03-14 |
2011-01-18 |
Yaupon Therapeutics Inc. |
Stabilized compositions of volatile alkylating agents and methods of using thereof
|
|
DE602006008625D1
(de)
|
2005-04-01 |
2009-10-01 |
Intezyne Technologies Inc |
Polymermicellen für die arzneistoffzufuhr
|
|
US20060229277A1
(en)
|
2005-04-08 |
2006-10-12 |
Orbus Pharma, Inc. |
Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor
|
|
US7728026B2
(en)
|
2005-04-11 |
2010-06-01 |
Abbott Laboratories, Inc. |
2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
|
|
WO2006123185A2
(en)
|
2005-05-19 |
2006-11-23 |
Merck Sharp & Dohme Limited |
Sulphamides for treatment of cancer
|
|
EA016838B1
(ru)
|
2005-06-07 |
2012-07-30 |
Йельский Университет |
Способы лечения рака и других заболеваний или патологических состояний с применением клевудина (lfmau) и телбивудина (ldt)
|
|
RU2408584C2
(ru)
|
2005-06-23 |
2011-01-10 |
Мерк Шарп Энд Домэ Корп. |
Ингибиторы тирозинкиназы
|
|
HUE035853T2
(en)
|
2005-07-18 |
2018-05-28 |
Seattle Genetics Inc |
Beta-glucuronide-linker-drug conjugates
|
|
CA2621983A1
(en)
|
2005-09-09 |
2007-03-22 |
Schering Corporation |
Azafused cyclin dependent kinase inhibitors
|
|
US8378117B2
(en)
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
|
WO2007069272A2
(en)
|
2005-10-21 |
2007-06-21 |
Panacea Biotec Limited |
Pharmaceutical composition comprising at least one anticancer drug and at least one polymer
|
|
EP1954277B1
(en)
|
2005-11-03 |
2017-01-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
|
AU2006322314A1
(en)
|
2005-11-18 |
2007-06-14 |
Synthon B.V. |
Zolpidem tablets
|
|
EP1968583A4
(en)
|
2005-12-20 |
2010-09-15 |
Harvard College |
COMPOUNDS, SCREENING AND TREATMENT PROCEDURES
|
|
WO2007081751A2
(en)
|
2006-01-05 |
2007-07-19 |
The Johns Hopkins University |
Compositions and methods for the treatment of cancer
|
|
US7910607B2
(en)
|
2006-03-10 |
2011-03-22 |
The Trustees Of California State University |
Nitroxide free radical synergized antineoplastic agents
|
|
WO2007106555A2
(en)
|
2006-03-14 |
2007-09-20 |
Neuren Pharmaceuticals Limited |
Oral formulations of glycyl-2-methylprolyl-glutamate
|
|
JP5162574B2
(ja)
|
2006-03-22 |
2013-03-13 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ｍｄｍ２及びｐ５３間の相互作用のインヒビターとしての環式アルキルアミン誘導体
|
|
EP2001851A2
(en)
|
2006-03-28 |
2008-12-17 |
Novartis AG |
Amide derivatives and their application for the treament of g protein related diseases
|
|
CA2645633A1
(en)
|
2006-04-05 |
2007-11-01 |
Novartis Ag |
Combinations of therapeutic agents for treating cancer
|
|
CA2649861A1
(en)
|
2006-04-26 |
2007-11-08 |
Merck & Co., Inc. |
Disubstituted aniline compounds
|
|
GB0609378D0
(en)
|
2006-05-11 |
2006-06-21 |
Novartis Ag |
Organic compounds
|
|
CA2651681A1
(en)
|
2006-05-18 |
2007-11-29 |
Merck & Co., Inc. |
Aryl-fused spirocyclic compounds
|
|
AU2007267843B2
(en)
|
2006-05-25 |
2011-10-13 |
Synta Pharmaceuticals Corp. |
Method for treating proliferative disorders associated with protooncogene products
|
|
US8183384B2
(en)
|
2006-05-25 |
2012-05-22 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate HSP90 activity
|
|
ES2559679T3
(es)
|
2006-06-20 |
2016-02-15 |
Abbvie Inc. |
Pirazoloquinazolinonas como inhibidores de PARP
|
|
US7964728B2
(en)
|
2006-07-06 |
2011-06-21 |
Solvay Pharmaceuticals B.V. |
Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition
|
|
US20080213249A1
(en)
|
2006-07-07 |
2008-09-04 |
The Scripps Research Insitute |
Use of Retro-Aldol Reaction to Generate Reactive Vinyl Ketone for Attachment to Antibody Molecules by Michael Addition Reaction for Use in Immunostaining and Immunotargeting
|
|
TW200813021A
(en)
|
2006-07-10 |
2008-03-16 |
Merck & Co Inc |
Tyrosine kinase inhibitors
|
|
WO2008009407A2
(en)
|
2006-07-17 |
2008-01-24 |
Novartis Ag |
Sulphonylaminocarbonyl derivatives of bile acid amides for use as immunomodulators
|
|
KR20090041391A
(ko)
|
2006-07-24 |
2009-04-28 |
테트랄로직 파마슈티칼스 |
이량체성 ｉａｐ 길항제
|
|
JP2010500370A
(ja)
|
2006-08-07 |
2010-01-07 |
ピーディーエル バイオファーマ，インコーポレイティド |
多発性硬化症を処置するための抗ｃｓ１抗体を用いる組成物および方法
|
|
US7683060B2
(en)
|
2006-08-07 |
2010-03-23 |
Incyte Corporation |
Triazolotriazines as kinase inhibitors
|
|
WO2008021364A2
(en)
|
2006-08-17 |
2008-02-21 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
|
US20080085882A1
(en)
*
|
2006-08-18 |
2008-04-10 |
University Of North Texas Health Science Center At Fort Worth |
Compositions and Methods for Potentiation of Cancer Agents
|
|
WO2008022771A1
(en)
|
2006-08-23 |
2008-02-28 |
Novartis Ag |
Amides as sphingomyeline inhibitors
|
|
CA2661333C
(en)
|
2006-08-23 |
2014-08-05 |
Eisai R&D Management Co., Ltd. |
Salt of phenoxypyridine derivative or crystal thereof and process for producing the same
|
|
US7956064B2
(en)
|
2006-09-01 |
2011-06-07 |
Cylene Pharmaceuticals, Inc. |
Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators
|
|
US8084471B2
(en)
|
2006-09-05 |
2011-12-27 |
Yale University |
Proteomimetic compounds as inhibitors of the interaction of nuclear receptor with coactivator peptides
|
|
BRPI0622054B8
(pt)
|
2006-09-22 |
2021-05-25 |
Oxford Amherst Llc |
composto e composição farmacêutica
|
|
EP2073802A1
(en)
|
2006-10-12 |
2009-07-01 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
WO2008046107A2
(en)
|
2006-10-13 |
2008-04-17 |
The Regents Of The University Of California |
Novel inhibitors of the egfr kinase targeting the asymmetric activating dimer interface
|
|
UY30639A1
(es)
|
2006-10-17 |
2008-05-31 |
Kudos Pharm Ltd |
Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
|
|
US7842278B2
(en)
|
2006-10-27 |
2010-11-30 |
Natural Pharmacia International, Inc. |
Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
|
|
MX2009004785A
(es)
|
2006-10-31 |
2009-06-05 |
Schering Corp |
Amidas 2-aminotiazol-4-carboxilicas como inhibidores de proteina quinasa.
|
|
BRPI0718029A2
(pt)
|
2006-11-06 |
2013-11-26 |
Supergen Inc |
Derivados de imidazo(1,2-b)piridazina e pirazolo(1,5-a)pirimidina e seu uso como inibidores da proteína cinase
|
|
US20120164075A1
(en)
|
2006-11-21 |
2012-06-28 |
Jina Pharmaceuticals, Inc. |
Endoxifen methods and compositions in the treatment of mammalian diseases
|
|
US20080125397A1
(en)
|
2006-11-28 |
2008-05-29 |
Telik, Inc. |
2 (SULFONYL)ETHYL N,N,N',N' tetrakis(2 chloroethyl)phosphorodia
|
|
US7655799B2
(en)
|
2006-11-29 |
2010-02-02 |
Telik, Inc. |
2{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidates
|
|
US8834920B2
(en)
|
2006-12-21 |
2014-09-16 |
Alza Corporation |
Liposome composition for targeting egfr receptor
|
|
US8536113B2
(en)
|
2006-12-21 |
2013-09-17 |
Janssen Biotech, Inc. |
EGFR binding peptides and uses thereof
|
|
US20080293648A1
(en)
|
2007-01-05 |
2008-11-27 |
Saha Pharmaceuticals, Inc. |
Compositions and Methods for Cancer Treatment
|
|
US8470323B2
(en)
|
2007-01-09 |
2013-06-25 |
The Trustees Of The University Of Pennsylvania |
Drug delivery to human tissues by single chain variable region antibody fragments cloned by phage display
|
|
US8398956B2
(en)
|
2007-01-11 |
2013-03-19 |
Immunomedics, Inc. |
In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
|
|
JP2010517976A
(ja)
|
2007-02-06 |
2010-05-27 |
ノバルティス アーゲー |
Ｃｃｒ９活性の阻害剤としての１−ベンゼンスルホニル−１ｈ−インドール誘導体
|
|
BRPI0807812A2
(pt)
|
2007-02-15 |
2020-06-23 |
Novartis Ag |
Combinações de lbh589 com outros agentes terapêuticos para tratar câncer
|
|
MX2009009183A
(es)
|
2007-02-28 |
2009-09-07 |
Inotek Pharmaceuticals Corp |
Analogos de indenoisoquinolinona y metodos de utilizacion de los mismos.
|
|
US8299256B2
(en)
|
2007-03-08 |
2012-10-30 |
Janssen Pharmaceutica Nv |
Quinolinone derivatives as PARP and TANK inhibitors
|
|
CA2680017C
(en)
|
2007-03-09 |
2013-11-12 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
|
US8501233B2
(en)
|
2007-03-13 |
2013-08-06 |
Wake Forest University |
Compositions and methods for treating cancer
|
|
WO2008116053A2
(en)
|
2007-03-20 |
2008-09-25 |
Trustees Of Tufts College |
Fap-activated chemotherapeutic compounds, and methods of use thereof
|
|
JP2010523670A
(ja)
|
2007-04-10 |
2010-07-15 |
エクセリクシス， インク． |
Ｐｉ３ｋアルファのピリドピリミジノン阻害剤を使用した治療方法
|
|
WO2008125627A1
(en)
|
2007-04-13 |
2008-10-23 |
Novartis Ag |
Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
|
|
CA2683946C
(en)
|
2007-04-18 |
2013-01-22 |
Merck & Co., Inc. |
Triazole derivatives which are smo antagonists
|
|
TWI448284B
(zh)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
雙效抗高血壓劑
|
|
AT505225A1
(de)
|
2007-04-26 |
2008-11-15 |
Sanochemia Pharmazeutika Ag |
0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen
|
|
US7838495B2
(en)
|
2007-04-27 |
2010-11-23 |
University Of Maryland, Baltimore |
Compositions and methods of use of EPB1, and ErbB3 binding protein
|
|
AU2008247592A1
(en)
|
2007-05-02 |
2008-11-13 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and pyrazoles useful as kinase inhibitors
|
|
PT2146721E
(pt)
|
2007-05-15 |
2013-07-18 |
Otsuka Pharma Co Ltd |
Métodos de utilização de antagonistas da vasopressina com agentes quimioterapeuticos de antraciclina para reduzir a cardiotoxicidade e/ou melhorar a sobrevivência
|
|
US20110021440A1
(en)
|
2007-05-16 |
2011-01-27 |
University Of Maryland, Baltimore |
Apoptotic pathway targeting for the diagnosis and treatment of cancer
|
|
US20110288023A1
(en)
|
2007-06-08 |
2011-11-24 |
The Regents Of The University Of California Office Of Technology Transfer |
Cancer drug delivery using modified transferrin
|
|
US8273890B2
(en)
|
2007-06-29 |
2012-09-25 |
4Sc Ag |
Thiophene-imidazopyridines
|
|
EP2178563A2
(en)
|
2007-07-06 |
2010-04-28 |
OSI Pharmaceuticals, Inc. |
Combination anti-cancer therapy comprising an inhibitor of both mtorc1 and mtorc2
|
|
ES2776406T3
(es)
|
2007-07-12 |
2020-07-30 |
Gitr Inc |
Terapias de combinación que emplean moléculas de enlazamiento a GITR
|
|
WO2009020933A2
(en)
|
2007-08-03 |
2009-02-12 |
Facet Biotech Corporation |
Therapeutic use of anti-tweak receptor antibodies
|
|
JP5282037B2
(ja)
|
2007-08-10 |
2013-09-04 |
田辺三菱製薬株式会社 |
新規なイソキノリン化合物の塩及びその結晶
|
|
EP3050566B1
(en)
|
2007-09-10 |
2018-11-28 |
Boston Biomedical, Inc. |
A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors
|
|
DK2209375T3
(da)
|
2007-10-03 |
2014-10-06 |
Eisai Inc |
Parp-inhibitorforbindelser, præparater og fremgangsmåder til anvendelse deraf
|
|
US20100311678A1
(en)
|
2007-10-04 |
2010-12-09 |
Bean Bruce P |
Methods and compositions for treating cancer and modulating signal transduction and metabolism pathways
|
|
RU2476441C2
(ru)
|
2007-10-19 |
2013-02-27 |
Сиэтл Дженетикс, Инк. |
Cd19-связывающие средства и их применение
|
|
US8183245B2
(en)
|
2007-10-25 |
2012-05-22 |
Merck Sharp & Dohme Corp. |
Pyrazine substituted pyrrolopyridines as inhibitors of JAK and PDK1
|
|
WO2009063970A1
(ja)
|
2007-11-14 |
2009-05-22 |
Forerunner Pharma Research Co., Ltd. |
抗gpr49抗体を用いる癌の診断および治療
|
|
ES2524787T3
(es)
|
2007-11-15 |
2014-12-12 |
Msd Italia S.R.L. |
Derivados de piridazinona como inhibidores de PARP
|
|
US8088749B2
(en)
|
2007-12-12 |
2012-01-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating cancer
|
|
US20110028422A1
(en)
|
2007-12-21 |
2011-02-03 |
Raquel Silvia Aloyz |
Combination of nilotinib and a nitrogen mustard analogue for the treatment of chronic lymphocytic leukemia
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
WO2009099736A2
(en)
|
2008-02-06 |
2009-08-13 |
Lead Therapeutics, Inc. |
Benzoxazole carboxamide inhibitors of poly(adp-ribose)polymerase (parp)
|
|
KR20100126361A
(ko)
|
2008-02-08 |
2010-12-01 |
에일러론 테라퓨틱스 인코포레이티드 |
치료용 펩티드유사 거대고리
|
|
US20090202540A1
(en)
|
2008-02-11 |
2009-08-13 |
Auspex Pharmaceuticals, Inc. |
Substituted oxazaphosphorines
|
|
WO2009109927A2
(en)
|
2008-03-05 |
2009-09-11 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
|
|
US8158616B2
(en)
|
2008-03-11 |
2012-04-17 |
Incyte Corporation |
Azetidine and cyclobutane derivatives as JAK inhibitors
|
|
ES2480994T3
(es)
|
2008-03-31 |
2014-07-29 |
Genentech, Inc. |
Compuestos de tipo benzopirano y benzoxepina inhibidores de PI3K y métodos de uso
|
|
EP2110377A1
(en)
|
2008-04-15 |
2009-10-21 |
DAC S.r.l. |
Spirocyclic derivatives as histone deacetylase inhibitors
|
|
KR20200058590A
(ko)
|
2008-04-30 |
2020-05-27 |
이뮤노젠 아이엔씨 |
가교제 및 그 용도
|
|
WO2009143018A2
(en)
|
2008-05-19 |
2009-11-26 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
CA2726317A1
(en)
|
2008-06-03 |
2009-12-10 |
Merck Sharp & Dohme Corp. |
Inhibitors of akt activity
|
|
GB2475183B
(en)
|
2008-06-04 |
2011-11-23 |
Gw Pharma Ltd |
Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators
|
|
EP2133334A1
(en)
|
2008-06-09 |
2009-12-16 |
DAC S.r.l. |
Heterocyclic derivatives as HDAC inhibitors
|
|
US8207195B2
(en)
|
2008-06-26 |
2012-06-26 |
Inspire Pharmaceuticals, Inc. |
Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds
|
|
PL2315756T3
(pl)
|
2008-07-08 |
2015-02-27 |
Incyte Holdings Corp |
1,2,5-oksadiazole jako inhibitory 2,3-dioksygenazy indoloaminy
|
|
JP2011527708A
(ja)
|
2008-07-11 |
2011-11-04 |
ニュメディックス |
減少した抗菌活性および神経保護作用の利点を有するテトラサイクリン誘導体
|
|
CA2726460C
(en)
|
2008-07-15 |
2017-02-21 |
F. Hoffmann-La Roche Ag |
Novel phenyl-imidazopyridines and pyridazines
|
|
ES2660418T3
(es)
|
2008-07-16 |
2018-03-22 |
Pharmacyclics Llc |
Inhibidores de la tirosina quinasa de Bruton para el tratamiento de tumores sólidos
|
|
WO2010009334A1
(en)
|
2008-07-17 |
2010-01-21 |
Colorado State University Research Foundation |
Method for preparing largazole analogs and uses thereof
|
|
US20120230991A1
(en)
|
2008-07-29 |
2012-09-13 |
Douglas Kim Graham |
Methods and compounds for enhancing anti-cancer therapy
|
|
WO2010021822A2
(en)
|
2008-07-30 |
2010-02-25 |
The Regents Of The University Of California |
Discovery of candidate biomarkers of in vivo apoptosis by global profiling of caspase cleavage sites
|
|
WO2010014913A1
(en)
|
2008-08-01 |
2010-02-04 |
Ventirx Pharmaceuticals, Inc. |
Toll-like receptor agonist formulations and their use
|
|
ES2625817T3
(es)
|
2008-08-06 |
2017-07-20 |
Medivation Technologies, Inc. |
Inhibidores de tipo Dihidropiridoftalazinona de poli(ADP-ribosa)polimerasa (PARP)
|
|
MX2011001938A
(es)
|
2008-08-26 |
2011-03-29 |
Boehringer Ingelheim Int |
Tienopirimidinas para composiciones farmaceuticas.
|
|
US20100068302A1
(en)
|
2008-09-17 |
2010-03-18 |
Traslational Cancer Drugs Pharma, S.L. |
Methods and compositions for the treatment of cancer
|
|
EP2346836B1
(en)
|
2008-10-08 |
2018-03-07 |
Cephalon, Inc. |
Processes for the preparation of bendamustine
|
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
|
US20100111901A1
(en)
|
2008-11-03 |
2010-05-06 |
Auspex Pharmaceuticals, Inc. |
Triazole inhibitors of aromatase
|
|
UY32240A
(es)
|
2008-11-14 |
2010-06-30 |
Boeringer Ingelheim Kg |
Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones.
|
|
WO2010068920A2
(en)
|
2008-12-12 |
2010-06-17 |
Auspex Pharmaceutical, Inc. |
Diaminoquinazoline inhibitors of dihydrofolate reductase
|
|
US20110318430A1
(en)
|
2008-12-18 |
2011-12-29 |
New York University |
Tumor therapy with antitumor agents in combination with sindbis virus-based vectors
|
|
US20100173013A1
(en)
|
2009-01-08 |
2010-07-08 |
Denis Drygin |
Treatment of neoplastic disorders using combination therapies
|
|
KR101779137B1
(ko)
|
2009-01-23 |
2017-09-18 |
다케다 야쿠힌 고교 가부시키가이샤 |
폴리(ａｄｐ-리보스)폴리머라제(ｐａｒｐ) 억제제
|
|
PL2565193T3
(pl)
|
2009-01-23 |
2014-07-31 |
Rigel Pharmaceuticals Inc |
Kompozycje i sposoby hamowania szlaku JAK
|
|
EP2393488B1
(en)
|
2009-02-06 |
2019-06-19 |
University Of Southern California |
Therapeutic compositions comprising monoterpenes
|
|
US8299077B2
(en)
|
2009-03-02 |
2012-10-30 |
Roche Palo Alto Llc |
Inhibitors of Bruton's tyrosine kinase
|
|
SG10201402977WA
(en)
|
2009-03-11 |
2014-09-26 |
Plexxikon Inc |
Pyrolo [2, 3-b] pyridine derivatives for the inhibition of raf kinases
|
|
CN103932972A
(zh)
|
2009-03-30 |
2014-07-23 |
天蓝制药公司 |
聚合物-药剂缀合物、颗粒、组合物和相关使用方法
|
|
WO2010114805A1
(en)
|
2009-03-31 |
2010-10-07 |
The Trustees Of The University Of Pennsylvania |
Methods of treating cancer with phenformin
|
|
US8680139B2
(en)
|
2009-04-01 |
2014-03-25 |
Progenra |
Anti-neoplastic compounds, compositions and methods
|
|
WO2010118063A2
(en)
|
2009-04-06 |
2010-10-14 |
Agios Pharmaceuticals, Inc. |
Therapeutic compositions and related methods of use
|
|
TW201040181A
(en)
|
2009-04-08 |
2010-11-16 |
Idenix Pharmaceuticals Inc |
Macrocyclic serine protease inhibitors
|
|
US20100291025A1
(en)
|
2009-04-13 |
2010-11-18 |
Auspex Pharmaceuticals, Inc. |
Indazole inhibitors of tyrosine kinase
|
|
CA2748414A1
(en)
|
2009-04-24 |
2010-10-28 |
F. Hoffmann-La Roche Ag |
Inhibitors of bruton's tyrosine kinase
|
|
US20110053968A1
(en)
|
2009-06-09 |
2011-03-03 |
Auspex Pharmaceuticals, Inc. |
Aminopyrimidine inhibitors of tyrosine kinase
|
|
US9151762B2
(en)
|
2009-06-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Identification of DSG-3 as a biomarker for the detection of metastasis in lymph nodes
|
|
TWI491606B
(zh)
|
2009-07-13 |
2015-07-11 |
Gilead Sciences Inc |
調節細胞凋亡信號之激酶的抑制劑
|
|
AU2010278067B2
(en)
*
|
2009-07-31 |
2016-10-27 |
Shin Maeda |
Cancer metastasis inhibitor
|
|
WO2011014257A1
(en)
|
2009-07-31 |
2011-02-03 |
The General Hospital Corporation |
Approaches to treat cancer using hb-egf inhibitors such as myrsinoic acid a
|
|
ES2432315T3
(es)
|
2009-08-28 |
2013-12-02 |
Takeda Pharmaceutical Company Limited |
Compuestos de hexahidrooxazinopterina para su uso como inhibidores de mTOR
|
|
US20110071115A1
(en)
|
2009-09-11 |
2011-03-24 |
Cylene Pharmaceuticals, Inc. |
Pharmaceutically useful heterocycle-substituted lactams
|
|
CA2774266A1
(en)
|
2009-09-16 |
2011-03-24 |
Cylene Pharmaceuticals, Inc. |
Novel tricyclic protein kinase modulators
|
|
ES2570569T3
(es)
|
2009-09-28 |
2016-05-19 |
Hoffmann La Roche |
Compuestos de benzoxazepina como inhibidores de la PI3K y métodos de uso
|
|
US7718662B1
(en)
|
2009-10-12 |
2010-05-18 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase
|
|
MY173390A
(en)
|
2009-10-23 |
2020-01-22 |
Takeda Pharmaceuticals Co |
Anti-gcc antibody molecules and related compositions and methods
|
|
ME03396B
(me)
|
2009-11-18 |
2020-01-20 |
Nektar Therapeutics |
Oblici kisele soli konjugata polimer-lek
|
|
CN102762208A
(zh)
|
2009-12-04 |
2012-10-31 |
赛林药物股份有限公司 |
作为ck2抑制剂的吡唑嘧啶和相关杂环
|
|
US20110195066A1
(en)
|
2010-02-05 |
2011-08-11 |
Auspex Pharmaceuticals, Inc. |
Quinoline inhibitors of tyrosine kinase
|
|
US8372451B2
(en)
|
2010-02-12 |
2013-02-12 |
Alexander Vuckovic, M.D., Llc |
Compositions and methods for treating depression
|
|
WO2011106248A2
(en)
|
2010-02-24 |
2011-09-01 |
Auspex Pharmaceuticals, Inc. |
Trimethoxyphenyl inhibitors of tyrosine kinase
|
|
EP2539343B1
(en)
|
2010-02-26 |
2015-12-30 |
Evotec International GmbH |
Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions
|
|
UY33241A
(es)
|
2010-02-26 |
2011-09-30 |
Boehringer Ingelheim Int |
?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?.
|
|
CN103002742B
(zh)
|
2010-03-05 |
2016-07-13 |
卡尔约药物治疗公司 |
核转运调节剂及其应用
|
|
EP2560634A1
(en)
|
2010-04-23 |
2013-02-27 |
Piramal Enterprises Limited |
Nitric oxide releasing prodrugs of therapeutic agents
|
|
JP5856151B2
(ja)
|
2010-05-12 |
2016-02-09 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
Ａｔｒキナーゼ阻害剤として有用な２−アミノピリジン誘導体
|
|
CA2800595C
(en)
|
2010-05-26 |
2018-04-24 |
Shriners Hospitals For Children |
Compositions comprising the nc2 domain of collagen ix and methods of using same
|
|
CN107898791A
(zh)
|
2010-06-03 |
2018-04-13 |
药品循环有限责任公司 |
布鲁顿酪氨酸激酶(btk)抑制剂的应用
|
|
US9155723B2
(en)
|
2010-06-28 |
2015-10-13 |
The General Hospital Corporation |
Anti-CXCR4 as a sensitizer to cancer therapeutics
|
|
CN107441493A
(zh)
*
|
2010-08-18 |
2017-12-08 |
德玛医药 |
制备用于改善未达最佳给药药物治疗的有效性和/或减少其副作用的药物的方法
|
|
US20120213854A1
(en)
|
2010-09-30 |
2012-08-23 |
Fetzer Oliver S |
Methods of treating a subject and related particles, polymers and compositions
|
|
CN103328496A
(zh)
|
2010-10-25 |
2013-09-25 |
中央研究院 |
癌靶向肽及其于癌症治疗与诊断的应用
|
|
JP2013545749A
(ja)
|
2010-11-10 |
2013-12-26 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
複素環化合物及びその使用
|
|
ME02395B
(me)
|
2010-11-12 |
2016-09-20 |
Pharma Mar Sa |
Kombinovana terapija sa antitumorskim alkaloidima
|
|
US20140088021A1
(en)
|
2011-05-27 |
2014-03-27 |
Nektar Therapeutics |
Water-Soluble Polymer-Linked Binding Moiety and Drug Compounds
|
|
US8637490B2
(en)
|
2011-07-01 |
2014-01-28 |
Uwm Research Foundation, Inc. |
Anti-cancer agents
|
|
CA2842195A1
(en)
|
2011-07-18 |
2013-01-24 |
Immunomedics, Inc. |
Fty720 increases cd74 expression and sensitizes cancer cells to anti-cd74 antibody-mediated cell death
|
|
BR112014017833A2
(pt)
*
|
2012-01-20 |
2021-03-23 |
Dennis Brown |
Uso de hexitóis substituídos incluindo dianidrogalactitol e análogos para tratar doença neoplástica e células-tronco de câncer incluindo glioblastoma multiforme e meduloblastoma
|
|
KR101374820B1
(ko)
|
2012-01-30 |
2014-03-17 |
광주과학기술원 |
페오포르바이드-α 컨쥬게이트 및 그의 용도
|
|
US8501724B1
(en)
|
2012-01-31 |
2013-08-06 |
Pharmacyclics, Inc. |
Purinone compounds as kinase inhibitors
|
|
JO3754B1
(ar)
|
2012-06-04 |
2021-01-31 |
Pharmacyclics Llc |
أشكال كريستالين لمثبط أنزيم كيناز تيروسين بروتون
|
|
US20140005148A1
(en)
|
2012-06-29 |
2014-01-02 |
Coldstream Laboratories Inc. |
Stable liquid formulations of nitrogen mustards
|